Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?

Health

Health
Allina to pause controversial practices for people with medical debt

Allina to pause controversial practices for people with medical debt

Last week, the New York Times published an investigation into Allina’s billing practices, alleging that the company refused to provide certain types of care for patients with at least $4,500 in medical debt. While the system would provide emergency care, the article said, it would withhold other services until that debt is paid off.
by Michelle Wiley

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
New study from UMN researchers says an existing drug is a promising treatment for long COVID

New study from UMN researchers says an existing drug is a promising treatment for long COVID

Metformin, a medication typically used as a treatment for Type 2 diabetes, has shown promise as an effective treatment for long COVID, according to a study by University of Minnesota researchers published Thursday in The Lancet.
by Michelle Wiley

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
FDA advisers endorse new RSV antibody drug for babies

FDA advisers endorse new RSV antibody drug for babies

A panel of experts to the Food and Drug Administration has recommended the agency approve a long-acting antibody drug that can protect infants from the seasonal virus, RSV.
by Pien Huang

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
Pope Francis is getting a hernia-related surgery in Rome

Pope Francis is getting a hernia-related surgery in Rome

The pope will undergo “a laparotomy and abdominal wall surgery under general anesthesia” on Wednesday, the Holy See's official news portal says. The pope had complained of abdominal pain on Tuesday.
by Bill Chappell

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!